Biohaven Announces Pricing of $175 Million Public Offering of Common Shares

Core Viewpoint - Biohaven Ltd. has announced a public offering of 23,333,334 common shares priced at $7.50 per share, aiming to raise approximately $175 million before expenses [1]. Group 1: Offering Details - The offering includes a 30-day option for underwriters to purchase an additional 3,500,000 shares at the public offering price [1]. - The expected closing date for the offering is November 13, 2025, pending customary closing conditions [1]. - The net proceeds from the offering will be used for general corporate purposes [1]. Group 2: Underwriters - J.P. Morgan, Goldman Sachs & Co. LLC, Leerink Partners, TD Cowen, and Cantor Fitzgerald are acting as book-running managers for the offering [2]. Group 3: Regulatory Information - The shares will be issued under an effective shelf registration statement on Form S-3, accessible through the SEC's website [4].